Design and value of immunohistochemical assays
26 Sep 2016
Design and value of immunohistochemical assays
Making sense of genetic associations with childhood leukaemia risk
Development of a novel CD19 CAR with improved functionality
Targeted therapies in melanoma
Treatment of cutaneous T cell lymphoma
Skin cancer lesions arising in uncommon regions
Targetted medicine to reduce melanoma mutational burden
VISMO trial to treat basal cell carcinoma
Checkpoint inhibitor therapy for treating melanoma
Tumour heterogeneity and the impact on patient care
State of the art imaging and lung cancer management
Recent advances and emerging therapies in lung cancer